- Home
- PPBT vs FMST Comparison
PPBT vs FMST Comparison
Compare PPBT & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- FMST
- Stock Information
- Founded
- PPBT 2010
- FMST 2005
- Country
- PPBT Israel
- FMST Canada
- Employees
- PPBT N/A
- FMST N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- PPBT Health Care
- FMST Basic Materials
- Exchange
- PPBT Nasdaq
- FMST Nasdaq
- Market Cap
- PPBT 7.1M
- FMST 7.1M
- IPO Year
- PPBT N/A
- FMST N/A
- Fundamental
- Price
- PPBT $2.65
- FMST $0.80
- Analyst Decision
- PPBT Strong Buy
- FMST
- Analyst Count
- PPBT 1
- FMST 0
- Target Price
- PPBT $33.00
- FMST N/A
- AVG Volume (30 Days)
- PPBT 12.3K
- FMST 54.4K
- Earning Date
- PPBT 03-10-2025
- FMST 01-01-0001
- Dividend Yield
- PPBT N/A
- FMST N/A
- EPS Growth
- PPBT N/A
- FMST N/A
- EPS
- PPBT N/A
- FMST N/A
- Revenue
- PPBT N/A
- FMST N/A
- Revenue This Year
- PPBT N/A
- FMST N/A
- Revenue Next Year
- PPBT N/A
- FMST N/A
- P/E Ratio
- PPBT N/A
- FMST N/A
- Revenue Growth
- PPBT N/A
- FMST N/A
- 52 Week Low
- PPBT $2.00
- FMST $0.55
- 52 Week High
- PPBT $20.60
- FMST $3.48
- Technical
- Relative Strength Index (RSI)
- PPBT 40.91
- FMST 45.23
- Support Level
- PPBT $2.64
- FMST $0.78
- Resistance Level
- PPBT $2.93
- FMST $0.90
- Average True Range (ATR)
- PPBT 0.15
- FMST 0.09
- MACD
- PPBT 0.02
- FMST 0.03
- Stochastic Oscillator
- PPBT 2.46
- FMST 67.66
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.